Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profit Rebound ⢠Thin Liquidity ⢠Heavy Payables AGL shows a meaningful near-term turnaround with quarterly profit and cash flow improving sharply, but thin liquidity and very large short-term liabilities keep the recovery fragile.
Price Behavior
Key Price Behavior Insights: ⢠Support Defense ⢠Choppy Rebound ⢠Capped Upside Support Level: $107-$108 Resistance Level: $115-$119 AGL stayed constructive over the last month, holding its $107-$108 support and gaining about 13% despite choppy volatility, but upside may remain capped near $115-$119 until it breaks out cleanly.
Sentiment & News
Key News Insights: ⢠Earnings inflection ⢠Raised guidance ⢠Gross savings growth AGL's improving earnings, raised guidance, and strong gross savings point to strengthening fundamentals, with investor focus now shifting to the August 5 Q2 results.
AI Summary
AGL now looks less like a distressed utility rebound and more like a capital-recycling turnaround, with FY2025 losses flipping to positive quarterly earnings and free cash flow, but the stock will only rerate if management proves divestiture-funded battery and flexible-capacity investments can convert this temporary margin recovery into durable EPS growth.
Description
agilon health, inc. provides healthcare services for senior patients through primary care physicians in communities across the United States. As of December 31, 2021, the company served about 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. Founded in 2016 and based in Austin, Texas, the company adopted its current name in March 2021.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 10 | Jun 17 | AGL | Agilon Health, Inc. | Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range. | Closed | +2.9% |
| May 21 | May 28 | AGL | Agilon Health, Inc. | High-risk but clear short-term momentum catalyst: 2026-05-06 Q1 update beat estimates and raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA. Stock surged sharply after earnings and is up about 206% over 21 trading days. | Closed | +12.2% |